[ad_1]
Synopsis
They are doubling down on the efforts to rein in the raging virus. Their trials, tribulations, triumphs, and tenacity offer a peek into the human side of those at the frontiers of scientific research in this period of adversity.
Inside a room crammed with lab equipment, Poulami Talukder spends hours gazing at a plethora of data blinking on her computer screen. The young scientist is part of a team of researchers at Boston-based Tiba Biotech. A spin-off from a Massachusetts Institute of Technology (MIT) incubator, Tiba is tiny compared with Wall Street pharma and biotech giants but its research is significant. Scientists at Tiba are focused on finding novel leads to
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Why ?
-
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
[ad_2]
Source link